[How much confidence may be placed in the biological diagnosis of pregnancy?].

F. Baron,M. Lemaire,Y. Michiels

1962-08-01

Abstract:

What problem does this paper attempt to address?

Optimal Gossip in Store-and-Forward Noncombining 2-D Tori

M. Soch,P. Tvrdík

DOI: https://doi.org/10.1007/BFb0002738

1997-08-26

Abstract:
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Tihamer Molnar,Andrea Lehoczki,Monika Fekete,Reka Varnai,Laszlo Zavori,Szabina Erdo-Bonyar,Diana Simon,Tímea Berki,Peter Csecsei,Erzsebet Ezer

DOI: https://doi.org/10.1007/s11357-024-01165-5

2024-04-26

GeroScience

Abstract:Abstract The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has introduced the medical community to the phenomenon of long COVID, a condition characterized by persistent symptoms following the resolution of the acute phase of infection. Among the myriad of symptoms reported by long COVID sufferers, chronic fatigue, cognitive disturbances, and exercise intolerance are predominant, suggesting systemic alterations beyond the initial viral pathology. Emerging evidence has pointed to mitochondrial dysfunction as a potential underpinning mechanism contributing to the persistence and diversity of long COVID symptoms. This review aims to synthesize current findings related to mitochondrial dysfunction in long COVID, exploring its implications for cellular energy deficits, oxidative stress, immune dysregulation, metabolic disturbances, and endothelial dysfunction. Through a comprehensive analysis of the literature, we highlight the significance of mitochondrial health in the pathophysiology of long COVID, drawing parallels with similar clinical syndromes linked to post-infectious states in other diseases where mitochondrial impairment has been implicated. We discuss potential therapeutic strategies targeting mitochondrial function, including pharmacological interventions, lifestyle modifications, exercise, and dietary approaches, and emphasize the need for further research and collaborative efforts to advance our understanding and management of long COVID. This review underscores the critical role of mitochondrial dysfunction in long COVID and calls for a multidisciplinary approach to address the gaps in our knowledge and treatment options for those affected by this condition.

geriatrics & gerontology,gerontology
Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Albert Leng,Manuj Shah,Syed Ameen Ahmad,Lavienraj Premraj,Karin Wildi,Gianluigi Li Bassi,Carlos A. Pardo,Alex Choi,Sung-Min Cho

DOI: https://doi.org/10.3390/cells12050816

IF: 6

2023-03-07

Cells

Abstract:The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed "long COVID" or post-acute sequela of COVID-19 (PASC), can implicate persistent neurological complications in up to one third of patients and present as fatigue, "brain fog", headaches, cognitive impairment, dysautonomia, neuropsychiatric symptoms, anosmia, hypogeusia, and peripheral neuropathy. Pathogenic mechanisms of these symptoms of long COVID remain largely unclear; however, several hypotheses implicate both nervous system and systemic pathogenic mechanisms such as SARS-CoV2 viral persistence and neuroinvasion, abnormal immunological response, autoimmunity, coagulopathies, and endotheliopathy. Outside of the CNS, SARS-CoV-2 can invade the support and stem cells of the olfactory epithelium leading to persistent alterations to olfactory function. SARS-CoV-2 infection may induce abnormalities in innate and adaptive immunity including monocyte expansion, T-cell exhaustion, and prolonged cytokine release, which may cause neuroinflammatory responses and microglia activation, white matter abnormalities, and microvascular changes. Additionally, microvascular clot formation can occlude capillaries and endotheliopathy, due to SARS-CoV-2 protease activity and complement activation, can contribute to hypoxic neuronal injury and blood–brain barrier dysfunction, respectively. Current therapeutics target pathological mechanisms by employing antivirals, decreasing inflammation, and promoting olfactory epithelium regeneration. Thus, from laboratory evidence and clinical trials in the literature, we sought to synthesize the pathophysiological pathways underlying neurological symptoms of long COVID and potential therapeutics.

cell biology
A review of cytokine-based pathophysiology of Long COVID symptoms

Russell N. Low,Ryan J. Low,Athena Akrami

DOI: https://doi.org/10.3389/fmed.2023.1011936

IF: 3.9

2023-03-31

Frontiers in Medicine

Abstract:The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is prolonged, or new symptoms are developed over months. Here, we propose a description of the pathophysiology of the Long COVID presentation based on inflammatory cytokine cascades and the p38 MAP kinase signaling pathways that regulate cytokine production. In this model, the SARS-CoV-2 viral infection is hypothesized to trigger a dysregulated peripheral immune system activation with subsequent cytokine release. Chronic low-grade inflammation leads to dysregulated brain microglia with an exaggerated release of central cytokines, producing neuroinflammation. Immunothrombosis linked to chronic inflammation with microclot formation leads to decreased tissue perfusion and ischemia. Intermittent fatigue, Post Exertional Malaise (PEM), CNS symptoms with “brain fog,” arthralgias, paresthesias, dysautonomia, and GI and ophthalmic problems can consequently arise as result of the elevated peripheral and central cytokines. There are abundant similarities between symptoms in Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). DNA polymorphisms and viral-induced epigenetic changes to cytokine gene expression may lead to chronic inflammation in Long COVID patients, predisposing some to develop autoimmunity, which may be the gateway to ME/CFS.

medicine, general & internal
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID

Aristo Vojdani,Elroy Vojdani,Evan Saidara,Michael Maes

DOI: https://doi.org/10.3390/v15020400

2023-01-31

Viruses

Abstract:A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a significant percentage of individuals within a few months after infection with SARS-CoV-2. This disorder is characterized by a wide range of persisting, returning or even new but related symptoms that involve different tissues and organs, including respiratory, cardiac, vascular, gastrointestinal, musculo-skeletal, neurological, endocrine and systemic. Some overlapping symptomatologies exist between long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Very much like with long ME/CFS, infections with herpes family viruses, immune dysregulation, and the persistence of inflammation have been reported as the most common pattern for the development of long COVID. This review describes several factors and determinants of long COVID that have been proposed, elaborating mainly on viral persistence, reactivation of latent viruses such as Epstein–Barr virus and human herpesvirus 6 which are also associated with the pathology of ME/CFS, viral superantigen activation of the immune system, disturbance in the gut microbiome, and multiple tissue damage and autoimmunity. Based on these factors, we propose diagnostic strategies such as the measurement of IgG and IgM antibodies against SARS-CoV-2, EBV, HHV-6, viral superantigens, gut microbiota, and biomarkers of autoimmunity to better understand and manage this multi-factorial disorder that continues to affect millions of people in the world.

virology
The Microbiota in Long COVID

Carmen Álvarez-Santacruz,Sylwia D. Tyrkalska,Sergio Candel

DOI: https://doi.org/10.3390/ijms25021330

IF: 5.6

2024-01-23

International Journal of Molecular Sciences

Abstract:Interest in the coronavirus disease 2019 (COVID-19) has progressively decreased lately, mainly due to the great effectivity of vaccines. Furthermore, no new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants able to circumvent the protection of these vaccines, while presenting high transmissibility and/or lethality, have appeared. However, long COVID has emerged as a huge threat to human health and economy globally. The human microbiota plays an important role in health and disease, participating in the modulation of innate and adaptive immune responses. Thus, multiple studies have found that the nasopharyngeal microbiota is altered in COVID-19 patients, with these changes associated with the onset and/or severity of the disease. Nevertheless, although dysbiosis has also been reported in long COVID patients, mainly in the gut, little is known about the possible involvement of the microbiota in the development of this disease. Therefore, in this work, we aim to fill this gap in the knowledge by discussing and comparing the most relevant studies that have been published in this field up to this point. Hence, we discuss that the relevance of long COVID has probably been underestimated, and that the available data suggest that the microbiota could be playing a pivotal role on the pathogenesis of the disease. Further research to elucidate the involvement of the microbiota in long COVID will be essential to explore new therapeutic strategies based on manipulation of the microbiota.

biochemistry & molecular biology,chemistry, multidisciplinary
Gut Microbiome Signatures During Acute Infection Predict Long COVID

Isin Yagmur Comba,Ruben T Mars,Lu Yang,Mitchell Dumais,Jun Y Chen,Trena M Van Gorp,Jonathan J. Harrington,Jason Paul Sinnwell,Stephen Johnson,La Rinda Holland,Adam K Khan,Efrem Lim,Christopher Aakre,Arjun Athreya,Georg K Gerber,John C. O'Horo,Konstantinos Lazaridis,Purna C Kashyap

DOI: https://doi.org/10.1101/2024.12.10.626852

2024-12-11

Abstract:Long COVID (LC), manifests in 10-30% of non-hospitalized individuals post-SARS-CoV-2 infection leading to significant morbidity. The predictive role of gut microbiome composition during acute infection in the development of LC is not well understood, partly due to the heterogeneous nature of disease. We conducted a longitudinal study of 799 outpatients tested for SARS-CoV-2 (380 positive, 419 negative) and found that individuals who later developed LC harbored distinct gut microbiome compositions during acute infection, compared with both SARS-CoV-positive individuals who did not develop LC and negative controls with similar symptomatology. However, the temporal changes in gut microbiome composition between the infectious (0-1 month) and post-infectious (1-2 months) phases was not different between study groups. Using machine learning, we showed that microbiome composition alone more accurately predicted LC than clinical variables. Including clinical data only marginally enhanced this prediction, suggesting that microbiome profiles during acute infection may reflect underlying health status and immune responses thus, help predicting individuals at risk for LC. Finally, we identified four LC symptom clusters, with gastrointestinal and fatigue-only groups most strongly linked to gut microbiome alterations.

Genomics
The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions

Altijana Hromić-Jahjefendić,Lejla Mahmutović,Abas Sezer,Tea Bećirević,Alberto Rubio-Casillas,Elrashdy M Redwan,Vladimir N Uversky

DOI: https://doi.org/10.1016/j.cytogfr.2024.08.002

2024-08-14

Abstract:Long COVID-19 affects a significant percentage of patients and is characterized by a wide range of symptoms, including weariness and mental fog as well as emotional symptoms like worry and sadness. COVID-19 is closely linked to the autoimmune disorders that are becoming more prevalent worldwide and are linked to immune system hyperactivation, neutrophil extracellular trap (NET) development, and molecular mimicry pathways. Long-term COVID-related autoimmune responses include a watchful immune system referring to the ability of immune system to constantly monitor the body for signs of infection, disease, or abnormal cells; altered innate and adaptive immune cells, autoantigens secreted by living or dead neutrophils, and high concentrations of autoantibodies directed against different proteins. The microbiome, which consists of billions of bacteria living in the human body, is essential for controlling immune responses and supporting overall health. The microbiome can affect the course of long COVID-associated autoimmunity, including the degree of illness, the rate of recovery, and the onset of autoimmune reactions. Although the precise role of the microbiome in long COVID autoimmunity is still being investigated, new studies indicate that probiotics, prebiotics, and dietary changes-interventions that target the microbiome-may be able to reduce autoimmune reactions and enhance long-term outcomes for COVID-19 survivors. More research is required to precisely understand how the microbiome affects COVID-19-related autoimmunity and to create tailored treatment plans.
The Candida Covid Connection: Preexisting Candida Overgrowth and Gut Dysbiosis Drives Long Covid

Patrick W. Chambers

DOI: https://doi.org/10.31579/2578-8868/283

2023-12-11

Neuroscience and Neurological Surgery

Abstract:Long Covid has become a blight, its economic consequences overwhelming. But Long Covid (LC) may represent persistent Covid-19 in those with preexisting Candida overgrowth (CO). The features shared by both are striking. LC may be a growing subset of CO. The altered tryptophan metabolism encountered in LC is driven by IFN-γ in reaction to CO. Females are robust producers of IFN-γ, yet estrogen promotes CO. The consequent decline in serotonin and melatonin triggers the mood swings and sleeplessness respectively in LC. The low serotonin, the primary messenger in the gut brain axis, creates autonomic dysfunction. The CO induced gut dysbiosis and leaky gut initiate an autoimmune path. TNFα seen in both LC and this opportunistic yeast is at the center of the cytokine triad that leads to neurodegeneration. The Western diet, high in carbohydrates, alcohol, and glutamate, is exploited by this commensal turned parasite. Residual SARS CoV2 and Candida generate abundant ROS, inducing mitochondrial dysfunction. Alcohol tastes different for many with LC, because acetaldehyde requires functioning hepatic mitochondria. This article delves into the complex physiology and biochemistry that drive the symptoms of this conspicuous connection. Recent research has revealed innovative approaches that might address this global scourge, including D-mannose for the immune dysfunction and butyrate for the gut dysbiosis created by and seen in both LC and intestinal Candidiasis.
Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications

Maha F. Alenazy,Haya I. Aljohar,Ashwag R. Alruwaili,Maha H. Daghestani,Mona A. Alonazi,Ranyah S. Labban,Afaf K. El-Ansary,Hanan A. Balto

DOI: https://doi.org/10.3390/metabo12100912

IF: 4.1

2022-09-28

Metabolites

Abstract:Increasing numbers of patients who recover from COVID-19 report lasting symptoms, such as fatigue, muscle weakness, dementia, and insomnia, known collectively as post-acute COVID syndrome or long COVID. These lasting symptoms have been examined in different studies and found to influence multiple organs, sometimes resulting in life-threating conditions. In this review, these symptoms are discussed in connection to the COVID-19 and long-COVID-19 immune changes, highlighting oral and psychiatric health, as this work focuses on the gut microbiota's link to long-COVID-19 manifestations in the liver, heart, kidney, brain, and spleen. A model of this is presented to show the biological and clinical implications of gut microbiota in SARS-CoV-2 infection and how they could possibly affect the therapeutic aspects of the disease. Probiotics can support the body's systems in fighting viral infections. This review focuses on current knowledge about the use of probiotics as adjuvant therapies for COVID-19 patients that might help to prevent long-COVID-19 complications.

biochemistry & molecular biology
A Mixed Method Systematic Review

Nawar Diar Bakerly,Nikki Smith,Julie L. Darbyshire,Joseph Kwon,Emily Bullock,Sareeta Baley,Manoj Sivan,Brendan Delaney

DOI: https://doi.org/10.3390/ijerph21040473

IF: 4.614

2024-04-13

International Journal of Environmental Research and Public Health

Abstract:Introduction: Long COVID (LC) is a global public health crisis affecting more than 70 million people. There is emerging evidence of different pathophysiological mechanisms driving the wide array of symptoms in LC. Understanding the relationships between mechanisms and symptoms helps in guiding clinical management and identifying potential treatment targets. Methods: This was a mixed-methods systematic review with two stages: Stage one (Review 1) included only existing systematic reviews (meta-review) and Stage two (Review 2) was a review of all primary studies. The search strategy involved Medline, Embase, Emcare, and CINAHL databases to identify studies that described symptoms and pathophysiological mechanisms with statistical analysis and/or discussion of plausible causal relationships between mechanisms and symptoms. Only studies that included a control arm for comparison were included. Studies were assessed for quality using the National Heart, Lung, and Blood Institute quality assessment tools. Results: 19 systematic reviews were included in Review 1 and 46 primary studies in Review 2. Overall, the quality of reporting across the studies included in this second review was moderate to poor. The pathophysiological mechanisms with strong evidence were immune system dysregulation, cerebral hypoperfusion, and impaired gas transfer in the lungs. Other mechanisms with moderate to weak evidence were endothelial damage and hypercoagulation, mast cell activation, and auto-immunity to vascular receptors. Conclusions: LC is a complex condition affecting multiple organs with diverse clinical presentations (or traits) underpinned by multiple pathophysiological mechanisms. A 'treatable trait' approach may help identify certain groups and target specific interventions. Future research must include understanding the response to intervention based on these mechanism-based traits.

public, environmental & occupational health,environmental sciences
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID

Giuseppe Ancona,Laura Alagna,Claudia Alteri,Emanuele Palomba,Anna Tonizzo,Andrea Pastena,Antonio Muscatello,Andrea Gori,Alessandra Bandera

DOI: https://doi.org/10.3389/fimmu.2023.1080043

IF: 7.3

2023-03-09

Frontiers in Immunology

Abstract:The gut microbiota plays a crucial role in human health and disease. Gut dysbiosis is known to be associated with increased susceptibility to respiratory diseases and modifications in the immune response and homeostasis of the lungs (the so-called gut-lung axis). Furthermore, recent studies have highlighted the possible role of dysbiosis in neurological disturbances, introducing the notion of the "gut-brain axis." During the last 2 years, several studies have described the presence of gut dysbiosis during coronavirus disease 2019 (COVID-19) and its relationship with disease severity, SARS-CoV-2 gastrointestinal replication, and immune inflammation. Moreover, the possible persistence of gut dysbiosis after disease resolution may be linked to long-COVID syndrome and particularly to its neurological manifestations. We reviewed recent evidence on the association between dysbiosis and COVID-19, investigating the possible epidemiologic confounding factors like age, location, sex, sample size, the severity of disease, comorbidities, therapy, and vaccination status on gut and airway microbial dysbiosis in selected studies on both COVID-19 and long-COVID. Moreover, we analyzed the confounding factors strictly related to microbiota, specifically diet investigation and previous use of antibiotics/probiotics, and the methodology used to study the microbiota (α- and β-diversity parameters and relative abundance tools). Of note, only a few studies focused on longitudinal analyses, especially for long-term observation in long-COVID. Lastly, there is a lack of knowledge regarding the role of microbiota transplantation and other therapeutic approaches and their possible impact on disease progression and severity. Preliminary data seem to suggest that gut and airway dysbiosis might play a role in COVID-19 and in long-COVID neurological symptoms. Indeed, the development and interpretation of these data could have important implications for future preventive and therapeutic strategies.

immunology
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome

Suguru Saito,Shima Shahbaz,Xian Luo,Mohammed Osman,Desiree Redmond,Jan Willem Cohen Tervaert,Liang Li,Shokrollah Elahi

DOI: https://doi.org/10.3389/fimmu.2024.1341843

IF: 7.3

2024-01-18

Frontiers in Immunology

Abstract:Introduction: A group of SARS-CoV-2 infected individuals present lingering symptoms, defined as long COVID (LC), that may last months or years post the onset of acute disease. A portion of LC patients have symptoms similar to myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), which results in a substantial reduction in their quality of life. A better understanding of the pathophysiology of LC, in particular, ME/CFS is urgently needed. Methods: We identified and studied metabolites and soluble biomarkers in plasma from LC individuals mainly exhibiting ME/CFS compared to age-sex-matched recovered individuals (R) without LC, acute COVID-19 patients (A), and to SARS-CoV-2 unexposed healthy individuals (HC). Results: Through these analyses, we identified alterations in several metabolomic pathways in LC vs other groups. Plasma metabolomics analysis showed that LC differed from the R and HC groups. Of note, the R group also exhibited a different metabolomic profile than HC. Moreover, we observed a significant elevation in the plasma pro-inflammatory biomarkers (e.g. IL-1α, IL-6, TNF-α, Flt-1, and sCD14) but the reduction in ATP in LC patients. Our results demonstrate that LC patients exhibit persistent metabolomic abnormalities 12 months after the acute COVID-19 disease. Of note, such metabolomic alterations can be observed in the R group 12 months after the acute disease. Hence, the metabolomic recovery period for infected individuals with SARS-CoV-2 might be long-lasting. In particular, we found a significant reduction in sarcosine and serine concentrations in LC patients, which was inversely correlated with depression, anxiety, and cognitive dysfunction scores. Conclusion: Our study findings provide a comprehensive metabolomic knowledge base and other soluble biomarkers for a better understanding of the pathophysiology of LC and suggests sarcosine and serine supplementations might have potential therapeutic implications in LC patients. Finally, our study reveals that LC disproportionally affects females more than males, as evidenced by nearly 70% of our LC patients being female.

immunology
Mechanisms of Gut-Related Viral Persistence in Long COVID

Philip McMillan,Anthony J Turner,Bruce D Uhal

DOI: https://doi.org/10.3390/v16081266

2024-08-07

Viruses

Abstract:Long COVID (post-acute sequelae of COVID-19-PASC) is a consequence of infection by SARS-CoV-2 that continues to disrupt the well-being of millions of affected individuals for many months beyond their first infection. While the exact mechanisms underlying PASC remain to be defined, hypotheses regarding the pathogenesis of long COVID are varied and include (but are not limited to) dysregulated local or systemic inflammatory responses, autoimmune mechanisms, viral-induced hormonal imbalances, skeletal muscle abnormalities, complement dysregulation, novel abzymes, and long-term persistence of virus and/or fragments of viral RNA or proteins. This review article is based on a comprehensive review of the wide range of symptoms most often observed in long COVID and an attempt to integrate that information into a plausible hypothesis for the pathogenesis of PASC. In particular, it is proposed that long-term dysregulation of the gut in response to viral persistence could lead to the myriad of symptoms observed in PASC.
Pathophysiological, immunological, and inflammatory features of long COVID

Karen Bohmwald,Benjamín Diethelm-Varela,Linmar Rodríguez-Guilarte,Thomas Rivera,Claudia A. Riedel,Pablo A. González,Alexis M. Kalergis

DOI: https://doi.org/10.3389/fimmu.2024.1341600

IF: 7.3

2024-02-29

Frontiers in Immunology

Abstract:The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality, overwhelming healthcare systems, and imposing substantial social and economic burdens on nations. While most of the attention and therapeutic efforts have concentrated on the acute phase of the disease, a notable proportion of survivors experience persistent symptoms post-infection clearance. This diverse set of symptoms, loosely categorized as long COVID, presents a potential additional public health crisis. It is estimated that 1 in 5 COVID-19 survivors exhibit clinical manifestations consistent with long COVID. Despite this prevalence, the mechanisms and pathophysiology of long COVID remain poorly understood. Alarmingly, evidence suggests that a significant proportion of cases within this clinical condition develop debilitating or disabling symptoms. Hence, urgent priority should be given to further studies on this condition to equip global public health systems for its management. This review provides an overview of available information on this emerging clinical condition, focusing on the affected individuals' epidemiology, pathophysiological mechanisms, and immunological and inflammatory profiles.

immunology
S234 COVID-19 Long COVID and Gut Dysbiosis

Adriana Vidal,Brad Barrows,Guanhui Bao,Amelia Goudzwaard,Andreas Papoutsis,Sabine Hazan

DOI: https://doi.org/10.14309/01.ajg.0001029304.22881.fe

2024-10-26

The American Journal of Gastroenterology

Abstract:Coronavirus disease 2019 (COVID-19) infection can trigger a chronic condition known as Long COVID, which as today still affects millions of U.S. adults and children and remains a major public health concern. In this study we investigated whether Long COVID patients have a distinct microbiome profile when compared to healthy controls.

gastroenterology & hepatology
Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder

Tsung-Hsien Chen,Chia-Jung Chang,Peir-Haur Hung

DOI: https://doi.org/10.3390/ijms24098034

IF: 5.6

2023-04-28

International Journal of Molecular Sciences

Abstract:Patients who have recovered from coronavirus disease 2019 (COVID-19) infection may experience chronic fatigue when exercising, despite no obvious heart or lung abnormalities. The present lack of effective treatments makes managing long COVID a major challenge. One of the underlying mechanisms of long COVID may be mitochondrial dysfunction. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can alter the mitochondria responsible for energy production in cells. This alteration leads to mitochondrial dysfunction which, in turn, increases oxidative stress. Ultimately, this results in a loss of mitochondrial integrity and cell death. Moreover, viral proteins can bind to mitochondrial complexes, disrupting mitochondrial function and causing the immune cells to over-react. This over-reaction leads to inflammation and potentially long COVID symptoms. It is important to note that the roles of mitochondrial damage and inflammatory responses caused by SARS-CoV-2 in the development of long COVID are still being elucidated. Targeting mitochondrial function may provide promising new clinical approaches for long-COVID patients; however, further studies are needed to evaluate the safety and efficacy of such approaches.

biochemistry & molecular biology,chemistry, multidisciplinary
The effect of bending radius on V-I characteristics of mono- and multicored BiPb-2223 tapes with and without Ag additions

I. Akimov,E. V. Antipova,S.N. Barabanov,N. Kozlenkova,P. Kuznetsov,A. Nikulin,D. N. Rakov,A. Shikov,N. Khlebova,D.A. Filitchev

DOI: https://doi.org/10.1109/77.620769

IF: 1.9489

1997-06-01

IEEE Transactions on Applied Superconductivity

Abstract:The effect of bending strain on Voltage-Current Characteristics (VCC) of BiPbSrCaCuO-2223/(Ag and Ag-alloy sheathed) tapes with and without Ag additions into the core have been studied. The testing probe allows us to carry out all set of bending tests up to radius 5 mm on the same specimen. The critical current Ic and shape of high-sensitivity VCC as a function of bending strain are analysed. Degradation of current carrying capacity under bending deformation is caused by the formation of microcracks. The overlapping of microcracks in Bi-2223/Ag sheathed tapes without Ag additions leads to current overflow into the Ag sheath and to appearance of linear resistance segment in the V-I curve at low electric field.
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Kailin Yin,Michael J. Peluso,Xiaoyu Luo,Reuben Thomas,Min-Gyoung Shin,Jason Neidleman,Alicer Andrew,Kyrlia C. Young,Tongcui Ma,Rebecca Hoh,Khamal Anglin,Beatrice Huang,Urania Argueta,Monica Lopez,Daisy Valdivieso,Kofi Asare,Tyler-Marie Deveau,Sadie E. Munter,Rania Ibrahim,Ludger Ständker,Scott Lu,Sarah A. Goldberg,Sulggi A. Lee,Kara L. Lynch,J. Daniel Kelly,Jeffrey N. Martin,Jan Münch,Steven G. Deeks,Timothy J. Henrich,Nadia R. Roan

DOI: https://doi.org/10.1038/s41590-023-01724-6

IF: 30.5

2024-01-12

Nature Immunology

Abstract:Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used 'omic" assays and serology to deeply characterize the global and SARS-CoV-2-specific immunity in the blood of individuals with clear LC and non-LC clinical trajectories, 8 months postinfection. We found that LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets. LC individuals displayed increased frequencies of CD4 + T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8 + T cells, higher levels of SARS-CoV-2 antibodies and a mis-coordination between their SARS-CoV-2-specific T and B cell responses. Our analysis suggested an improper crosstalk between the cellular and humoral adaptive immunity in LC, which can lead to immune dysregulation, inflammation and clinical symptoms associated with this debilitating condition.

immunology
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2

Kailin Yin,Michael J Peluso,Xiaoyu Luo,Reuben Thomas,Min-Gyoung Shin,Jason Neidleman,Alicer Andrew,Kyrlia Young,Tongcui Ma,Rebecca Hoh,Khamal Anglin,Beatrice Huang,Urania Argueta,Monica Lopez,Daisy Valdivieso,Kofi Asare,Tyler-Marie Deveau,Sadie E Munter,Rania Ibrahim,Ludger Ständker,Scott Lu,Sarah A Goldberg,Sulggi A Lee,Kara L Lynch,J Daniel Kelly,Jeffrey N Martin,Jan Münch,Steven G Deeks,Timothy J Henrich,Nadia R Roan

DOI: https://doi.org/10.1101/2023.02.09.527892

2023-08-04

bioRxiv

Abstract:Long COVID (LC), a type of post-acute sequelae of SARS-CoV-2 infection (PASC), occurs after at least 10% of SARS-CoV-2 infections, yet its etiology remains poorly understood. Here, we used multiple "omics" assays (CyTOF, RNAseq/scRNAseq, Olink) and serology to deeply characterize both global and SARS-CoV-2-specific immunity from blood of individuals with clear LC and non-LC clinical trajectories, 8 months following infection and prior to receipt of any SARS-CoV-2 vaccine. Our analysis focused on deep phenotyping of T cells, which play important roles in immunity against SARS-CoV-2 yet may also contribute to COVID-19 pathogenesis. Our findings demonstrate that individuals with LC exhibit systemic inflammation and immune dysregulation. This is evidenced by global differences in T cell subset distribution in ways that imply ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets. Individuals with LC harbored increased frequencies of CD4+ T cells poised to migrate to inflamed tissues, and exhausted SARS-CoV-2-specific CD8+ T cells. They also harbored significantly higher levels of SARS-CoV-2 antibodies, and in contrast to non-LC individuals, exhibited a mis-coordination between their SARS-CoV-2-specific T and B cell responses. RNAseq/scRNAseq and Olink analyses similarly revealed immune dysregulatory mechanisms, along with non-immune associated perturbations, in individuals with LC. Collectively, our data suggest that proper crosstalk between the humoral and cellular arms of adaptive immunity has broken down in LC, and that this, perhaps in the context of persistent virus, leads to the immune dysregulation, inflammation, and clinical symptoms associated with this debilitating condition.

[How much confidence may be placed in the biological diagnosis of pregnancy?].

Optimal Gossip in Store-and-Forward Noncombining 2-D Tori

Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

A review of cytokine-based pathophysiology of Long COVID symptoms

Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID

The Microbiota in Long COVID

Gut Microbiome Signatures During Acute Infection Predict Long COVID

The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions

The Candida Covid Connection: Preexisting Candida Overgrowth and Gut Dysbiosis Drives Long Covid

Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications

A Mixed Method Systematic Review

Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID

Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome

Mechanisms of Gut-Related Viral Persistence in Long COVID

Pathophysiological, immunological, and inflammatory features of long COVID

S234 COVID-19 Long COVID and Gut Dysbiosis

Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder

The effect of bending radius on V-I characteristics of mono- and multicored BiPb-2223 tapes with and without Ag additions

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2